Barry McAleer, PhD. MBA
Chief Executive Officer, NextGen Sciences Inc
Dr McAleer has a degree in Biochemistry and a PhD in Molecular Virology with over 15yrs of hands on experience in molecular biology and proteins. Dr. McAleer has worked in the biotech industry for almost 10yrs. He has managed laboratory research groups within academia and biotech and has headed up a CRO business unit delivering to biotech and pharma clients.
Dr McAleer has previously held positions as Business Development Manager, Piramal Healthcare; Business Support Manager, Cels; Head of Contract Services, NextGen Sciences Ltd and Group Leader, Science, NextGen Sciences Ltd. Dr. McAleer was appointed in 2009 as Head Global Sales & Marketing at NextGen Group Plc and to the position of Chief Executive Officer of NextGen Sciences Inc. in August 2010. Dr McAleer sits on the board of NextGen Group Plc
Glenn Barney
VP Business Development
Mr Barney brings to NextGen Sciences over 25 years of experience with global pharmaceutical companies and the life science industry. His expertise includes building and managing global sales, service and product support teams, overseeing multiple product launches and engineering product line strategies.
Mr Barney also has extensive operations and business development experience. Prior to joining the NextGen team, Mr Barney was responsible for the commercialization of the Decision Biomarkers workstation and Biochips. Mr Barney has also held leadership positions at PerkinElmer, Inc. where he managed key accounts, while continuously driving top-line revenue growth.
Mr. Barney has managed major accounts including Hoffman-La Roche, Pfizer, Novartis, Merck, Abbott, GlaxoSmithKline, Johnson & Johnson and BMS. Mr Barney also held senior positions and played instrumental roles developing product lines and overseeing full product divisions at both PerkinElmer and ThermoElectron. Mr. Barney holds a BA in Biology from Boston University.
Ian Kelly
VP Technology
Mr. Kelly joined the company in January 2001 and has been responsible for the development of software and automation for a variety of different products including the ProteinArray Workstation, a2DEoptimizer and more recently the ExpressionFactory and ExpressionWorkstation protein expression platforms. He now heads the team implementing a Laboratory Information Management System and developing automated sample preparation capabilities for the company’s biomarker testing division. Mr. Kelly has extensive product development experience in a variety of different industries, including avionics, petrochemical, and transportation.
Prior to joining NextGen Sciences, Mr. Kelly worked at Terrington Systems as Principal Engineer where he led a multi-disciplinary team developing an innovative high-performance aircraft data recorder and data-warehousing system for a variety of different customers including the UK Ministry of Defence, BAE SYSTEMS and NASA. Previously he worked at the engineering consultancy Oscar Faber as Senior Consultant, managing the design and development of transportation information and control systems.
